Thermo Fisher price target raised to $730 from $580 at RBC Capital
The substantial target revision is a positive signal, but the limited remaining target-implied upside tempers its strength.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The substantial target revision is a positive signal, but the limited remaining target-implied upside tempers its strength.
What happened, with direct paths to the underlying reporting
RBC Capital raised its TMO target by about 26% to $730; the target is about 6% above the posted price of $687.49.
Target: $730
Posted price: $687.49
Analyst firm: RBC Capital
Analyst: Dan Leonard
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.